Literature DB >> 33879616

Caveolar peroxynitrite formation impairs endothelial TRPV4 channels and elevates pulmonary arterial pressure in pulmonary hypertension.

Zdravka Daneva1, Corina Marziano1, Matteo Ottolini1,2, Yen-Lin Chen1, Thomas M Baker1, Maniselvan Kuppusamy1, Aimee Zhang3, Huy Q Ta3, Claire E Reagan4, Andrew D Mihalek5, Ramesh B Kasetti6,7, Yuanjun Shen8,9,10,11, Brant E Isakson1,12, Richard D Minshall13,14, Gulab S Zode6,7, Elena A Goncharova8,9,10,11, Victor E Laubach3, Swapnil K Sonkusare15,2,12.   

Abstract

Recent studies have focused on the contribution of capillary endothelial TRPV4 channels to pulmonary pathologies, including lung edema and lung injury. However, in pulmonary hypertension (PH), small pulmonary arteries are the focus of the pathology, and endothelial TRPV4 channels in this crucial anatomy remain unexplored in PH. Here, we provide evidence that TRPV4 channels in endothelial cell caveolae maintain a low pulmonary arterial pressure under normal conditions. Moreover, the activity of caveolar TRPV4 channels is impaired in pulmonary arteries from mouse models of PH and PH patients. In PH, up-regulation of iNOS and NOX1 enzymes at endothelial cell caveolae results in the formation of the oxidant molecule peroxynitrite. Peroxynitrite, in turn, targets the structural protein caveolin-1 to reduce the activity of TRPV4 channels. These results suggest that endothelial caveolin-1-TRPV4 channel signaling lowers pulmonary arterial pressure, and impairment of endothelial caveolin-1-TRPV4 channel signaling contributes to elevated pulmonary arterial pressure in PH. Thus, inhibiting NOX1 or iNOS activity, or lowering endothelial peroxynitrite levels, may represent strategies for restoring vasodilation and pulmonary arterial pressure in PH.

Entities:  

Keywords:  TRP channel; caveolin; endothelium; peroxynitrite; pulmonary hypertension

Mesh:

Substances:

Year:  2021        PMID: 33879616      PMCID: PMC8092599          DOI: 10.1073/pnas.2023130118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  63 in total

Review 1.  Endothelial dysfunction in pulmonary hypertension.

Authors:  Rohit Budhiraja; Rubin M Tuder; Paul M Hassoun
Journal:  Circulation       Date:  2004-01-20       Impact factor: 29.690

2.  Elafin Reverses Pulmonary Hypertension via Caveolin-1-Dependent Bone Morphogenetic Protein Signaling.

Authors:  Nils P Nickel; Edda Spiekerkoetter; Mingxia Gu; Caiyun G Li; Hai Li; Mark Kaschwich; Isabel Diebold; Jan K Hennigs; Ki-Yoon Kim; Kazuya Miyagawa; Lingli Wang; Aiqin Cao; Silin Sa; Xinguo Jiang; Raymond W Stockstill; Mark R Nicolls; Roham T Zamanian; Richard D Bland; Marlene Rabinovitch
Journal:  Am J Respir Crit Care Med       Date:  2015-06-01       Impact factor: 21.405

3.  Involvement of TRPV1 and TRPV4 channels in migration of rat pulmonary arterial smooth muscle cells.

Authors:  Elodie Martin; Diana Dahan; Guillaume Cardouat; Jennifer Gillibert-Duplantier; Roger Marthan; Jean-Pierre Savineau; Thomas Ducret
Journal:  Pflugers Arch       Date:  2012-07-22       Impact factor: 3.657

Review 4.  Nitric oxide deficiency and endothelial dysfunction in pulmonary arterial hypertension.

Authors:  James R Klinger; Steven H Abman; Mark T Gladwin
Journal:  Am J Respir Crit Care Med       Date:  2013-09-15       Impact factor: 21.405

5.  Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration.

Authors:  You-Yang Zhao; Yidan D Zhao; Muhammad K Mirza; Julia H Huang; Hari-Hara S K Potula; Steven M Vogel; Viktor Brovkovych; Jason X-J Yuan; John Wharton; Asrar B Malik
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

6.  Role of caveolar compartmentation in endothelium-derived hyperpolarizing factor-mediated relaxation: Ca2+ signals and gap junction function are regulated by caveolin in endothelial cells.

Authors:  J Saliez; C Bouzin; G Rath; P Ghisdal; F Desjardins; R Rezzani; L F Rodella; J Vriens; B Nilius; O Feron; J-L Balligand; C Dessy
Journal:  Circulation       Date:  2008-02-11       Impact factor: 29.690

7.  Analysis of responses to the TRPV4 agonist GSK1016790A in the pulmonary vascular bed of the intact-chest rat.

Authors:  Edward A Pankey; Andrea Zsombok; George F Lasker; Philip J Kadowitz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-01       Impact factor: 4.733

8.  Reciprocal regulation of eNOS and caveolin-1 functions in endothelial cells.

Authors:  Zhenlong Chen; Suellen D S Oliveira; Adriana M Zimnicka; Ying Jiang; Tiffany Sharma; Stone Chen; Orly Lazarov; Marcelo G Bonini; Jacob M Haus; Richard D Minshall
Journal:  Mol Biol Cell       Date:  2018-03-22       Impact factor: 4.138

9.  Urgent reconsideration of lung edema as a preventable outcome in COVID-19: inhibition of TRPV4 represents a promising and feasible approach.

Authors:  Wolfgang M Kuebler; Sven-Eric Jordt; Wolfgang B Liedtke
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-05-13       Impact factor: 5.464

10.  Arterial response to shear stress critically depends on endothelial TRPV4 expression.

Authors:  Veronika Hartmannsgruber; Willm-Thomas Heyken; Michael Kacik; Anuradha Kaistha; Ivica Grgic; Christian Harteneck; Wolfgang Liedtke; Joachim Hoyer; Ralf Köhler
Journal:  PLoS One       Date:  2007-09-05       Impact factor: 3.240

View more
  8 in total

Review 1.  Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies.

Authors:  Helen Christou; Raouf A Khalil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-02-25       Impact factor: 4.733

2.  Novel Smooth Muscle Ca2+-Signaling Nanodomains in Blood Pressure Regulation.

Authors:  Zdravka Daneva; Maniselvan Kuppusamy; Yen-Lin Chen; Matteo Ottolini; Thomas M Baker; Eliska Klimentova; Soham A Shah; Jennifer D Sokolowski; Min S Park; Swapnil K Sonkusare
Journal:  Circulation       Date:  2022-06-27       Impact factor: 39.918

3.  Puerarin-V prevents the progression of hypoxia- and monocrotaline-induced pulmonary hypertension in rodent models.

Authors:  Di Chen; Hui-Fang Zhang; Tian-Yi Yuan; Shu-Chan Sun; Ran-Ran Wang; Shou-Bao Wang; Lian-Hua Fang; Yang Lyu; Guan-Hua Du
Journal:  Acta Pharmacol Sin       Date:  2022-02-21       Impact factor: 7.169

4.  The association between the restriction of daily life and depression during the COVID-19 pandemic in Korea: a nationwide based survey.

Authors:  Sunwoo Cho; Hyo Rim Ju; Hyoungseok Oh; Eun-Suk Choi; Jung Ah Lee
Journal:  Sci Rep       Date:  2022-10-21       Impact factor: 4.996

Review 5.  Role of TRP ion channels in cerebral circulation and neurovascular communication.

Authors:  Maniselvan Kuppusamy; Matteo Ottolini; Swapnil K Sonkusare
Journal:  Neurosci Lett       Date:  2021-09-22       Impact factor: 3.046

Review 6.  Redox Switches Controlling Nitric Oxide Signaling in the Resistance Vasculature and Implications for Blood Pressure Regulation: Mid-Career Award for Research Excellence 2020.

Authors:  Atinuke Aramide Modupe Dosunmu-Ogunbi; Joseph C Galley; Shuai Yuan; Heidi M Schmidt; Katherine C Wood; Adam C Straub
Journal:  Hypertension       Date:  2021-08-23       Impact factor: 9.897

7.  Endothelial pannexin 1-TRPV4 channel signaling lowers pulmonary arterial pressure in mice.

Authors:  Zdravka Daneva; Matteo Ottolini; Yen Lin Chen; Eliska Klimentova; Maniselvan Kuppusamy; Soham A Shah; Richard D Minshall; Cheikh I Seye; Victor E Laubach; Brant E Isakson; Swapnil K Sonkusare
Journal:  Elife       Date:  2021-09-07       Impact factor: 8.140

8.  Restricted Intimal Ca2+ Signaling Associated With Cardiovascular Disease.

Authors:  Mark S Taylor; Jordan Lowery; Chung-Sik Choi; Michael Francis
Journal:  Front Physiol       Date:  2022-03-22       Impact factor: 4.755

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.